Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Dec;50(6):785–791. doi: 10.1038/bjc.1984.257

The effect of vasopressin and hepatic artery ligation on the blood supply to normal and metastatic liver tissue.

S A Jenkins, D W Day, B Mooney, P Devitt, I Taylor, R Shields
PMCID: PMC1977014  PMID: 6498075

Abstract

The effect of low (0.08 microU g-1 body wt min-1) and high (0.16 microU g-1 body wt min-1) rates of vasopressin infusion on blood flow to normal liver tissue and to liver metastases derived from azoxymethane induced colorectal carcinomas was studied in 36 male Wistar rats. Portal venous flow was measured by electromagnetic flowmetry and blood flow to normal and metastatic liver tissue by the clearance of xenon-133 injected directly into the liver parenchyma or metastasis. The low rate of vasopressin infusion decreased portal venous flow but increased blood flow to normal and metastatic liver tissue while at the higher rate of infusion these effects were reversed. Hepatic artery ligation (HAL) immediately following a low rate of vasopressin infusion abolished the observed increase in blood flow to both normal liver tissue and metastases. HAL immediately following the higher rate of vasopressin infusion further reduced blood flow to metastases but did not further alter blood flow to normal liver tissue. HAL prior to the infusion of the vasoactive drug significantly reduced blood flow to metastatic liver tissue, increased portal venous flow and was without effect on blood flow to normal liver tissue. Following HAL, blood flow to metastatic liver tissue was not further altered by either the low or high rates of vasopressin infusion. However, blood flow to normal liver tissue after HAL was reduced by a low rate of infusion of vasopressin and increased by the higher rate of infusion. The results of this study indicate that blood flow to normal or metastatic liver tissue can be increased or decreased by differential rates of infusion of vasopressin. These observations may have important implications in the treatment of liver metastases in man where different rates of vasopressin infusion may potentiate the effects of hepatic artery ligation or cytotoxic therapy.

Full text

PDF
785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BREEDIS C., YOUNG G. The blood supply of neoplasms in the liver. Am J Pathol. 1954 Sep-Oct;30(5):969–977. [PMC free article] [PubMed] [Google Scholar]
  2. Bengmark S., Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969 Jan;23(1):198–202. doi: 10.1002/1097-0142(196901)23:1<198::aid-cncr2820230126>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  3. CONN H. L., Jr Equilibrium distribution of radioxenon in tissue: xenon-hemoglobin association curve. J Appl Physiol. 1961 Nov;16:1065–1070. doi: 10.1152/jappl.1961.16.6.1065. [DOI] [PubMed] [Google Scholar]
  4. Chojkier M., Groszmann R. J., Atterbury C. E., Bar-Meir S., Blei A. T., Frankel J., Glickman M. G., Kniaz J. L., Schade R., Taggart G. J. A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices. Gastroenterology. 1979 Sep;77(3):540–546. [PubMed] [Google Scholar]
  5. Grage T. B., Vassilopoulos P. P., Shingleton W. W., Jubert A. V., Elias E. G., Aust J. B., Moss S. E. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery. 1979 Oct;86(4):550–555. [PubMed] [Google Scholar]
  6. KEHNE J. H., HUGHES F. A., GOMPERTZ M. L. The use of surgical pituitrin in the control of esophageal varix bleeding; an experimental study and report of two cases. Surgery. 1956 Jun;39(6):917–925. [PubMed] [Google Scholar]
  7. Lewis D. H. Intra-operative blood flow measurements with the xenon washout technique. Prog Surg. 1970;8:74–101. doi: 10.1159/000386311. [DOI] [PubMed] [Google Scholar]
  8. Mackenzie R. J., Leiberman D. P., Mathie R. T., Rice G. C., Harper A. M., Blumgart L. H. Liver blood flow measurement the interpretation of xenon133 clearance curves. Acta Chir Scand. 1976;142(7):519–525. [PubMed] [Google Scholar]
  9. Mattsson W., Jonsson K., Hellekant C., Hallsten L. Short-term intra-arterial mitomycin C in hepatic metastases. Acta Radiol Oncol. 1980;19(5):321–325. doi: 10.3109/02841868009131314. [DOI] [PubMed] [Google Scholar]
  10. Mooney B., Taylor I. The effect of hepatic arterial ligation on spontaneously developing colorectal liver metastases in the rat. Clin Oncol. 1982;8(3):231–235. [PubMed] [Google Scholar]
  11. Nakakuma K., Tashiro S., Hiraoka T., Konno T., Yokoyama I. A non-resectable hepatoma after hepatic artery ligation combined with infusion chemotherapy--an eight-year survival. Jpn J Surg. 1981 Mar;11(2):80–83. doi: 10.1007/BF02468873. [DOI] [PubMed] [Google Scholar]
  12. Nielsen J., Balslev I., Fenger H. J., Jensen H. E., Kragelund E. Carcinoma of the rectum with liver metastases. Prognosis and operative indications. Acta Chir Scand. 1973;139(5):479–481. [PubMed] [Google Scholar]
  13. Oxley E. M., Ellis H. Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg. 1969 Feb;56(2):149–152. doi: 10.1002/bjs.1800560217. [DOI] [PubMed] [Google Scholar]
  14. Reed M. L., Vaitkevicius V. K., Al-Sarraf M., Vaughn C. B., Singhakowinta A., Sexon-Porte M., Izbicki R., Baker L., Straatsma G. W. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer. 1981 Jan 15;47(2):402–409. doi: 10.1002/1097-0142(19810115)47:2<402::aid-cncr2820470231>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  15. Richardson P. D., Withrington P. G. Liver blood flow. II. Effects of drugs and hormones on liver blood flow. Gastroenterology. 1981 Aug;81(2):356–375. [PubMed] [Google Scholar]
  16. Richardson P. D., Withrington P. G. The effects of intra-arterial and intraportal injections of vasopressin on the simultaneously perfused hepatic arterial and portal venous vascular beds of the dog. Circ Res. 1978 Oct;43(4):496–503. doi: 10.1161/01.res.43.4.496. [DOI] [PubMed] [Google Scholar]
  17. Shields R. The management of portal hypertension and bleeding oesophageal varices. Br J Hosp Med. 1977 Feb;17(2):126, 128-30, 132 passim. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES